Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01387698
Other study ID # FE999907 CS09
Secondary ID
Status Completed
Phase N/A
First received June 29, 2011
Last updated October 28, 2015
Start date June 2011
Est. completion date October 2015

Study information

Verified date October 2015
Source Ferring Pharmaceuticals
Contact n/a
Is FDA regulated No
Health authority France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santéFrance: French Data Protection AuthorityFrance: Conseil National de l'Ordre des Médecins
Study type Observational

Clinical Trial Summary

The primary objective of this study is to confirm the long-term efficacy (remission and maintenance in remission) of current validated treatments. Each patient will be followed during 3 years in this non-interventional trial.


Recruitment information / eligibility

Status Completed
Enrollment 812
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years old or above

- Ulcerative colitis, whatever the extension, in mild to moderate flare-up (including proctitis)

- Having received the information sheet

Exclusion Criteria:

- Participating, at the time of inclusion, in another study using an investigational drug or device

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
France Centre Hospitalier pays d aix Aix en Provence Cedex 1
France Investigational site Amboise
France Cabinet Médical Amiens
France CMAD Amiens
France Clinique Saint Joseph Angers
France Investigational site Anglet
France Cabinet Médical Arras
France Hopital Robert Ballanger Aulnay Sous Bois Cedex
France Investigational site Aulnays Sous Bois
France Polyclinique Ste Marguerite Auxerre
France Investigational site Beausoleil
France Clinique ANNE D'ERTOIS Bethune
France Le Rabelais Beziers
France Centre Hospitalier de Blois Blois
France Investigational site Bordeaux
France CH de Bourg-en Bresse Hopital de Fleyriart (Viriat) Bourg En Bresse Cedex
France Polyclinique Jean Villar Bruges Cedex
France Cabinet Médical Caen
France Cabinet Medical Cahors
France Polyclinic Montréal Carcassonne
France Investigational site Carpentras
France Maison de Consultations Cesson Sevigne Cedex
France Investigational site Challes Les Eaux
France CH de Chambery Chambery
France Pole Santé Léonard de Vinci Chambray Les Tours
France Cabinet Médical Charleville Mezieres
France Centre Hospitalier du Haut Anjou Hospital St Julien Château Gontier
France Cabinet Médical Chateaubriant
France Cabinet Médical Chateauroux
France Hospital Chateauroux
France Investigational site Chateauroux
France CH Chateauroux Chateauroux Cedex
France Cabinet Médical Cherbourg
France Investigational site Chinon
France Cabinet Médical Clermont Ferrand Cedex 2
France Cabinet Médical Colombes
France Clinique des Cèdres Cornebarrieu
France Centre Hospitalier LAENNEC Creil Cedex
France Hospital Creteil
France Investigational site Creteil
France CHI Créteil Creteil Cedex
France Hospital Creteil Cedex
France Cabinet Médical Dax
France Cabinet Médical Decines Charpieu
France Investigational site Dijon
France Investigational site Dole
France Octogone Draguignan
France Hospital De Dreux Dreux
France Hopital Simone Veil Eaubonne
France Cabinet Médical Echirolles
France Clinic De La Présentation Fleury-les-aubrais
France Centre Hospitalier du Val d'Ariège Foix CEDEX
France Investigational site Fontenay Le Comte
France Investigational site Gien
France Cabinet Médical Grenoble
France Investigational site Guigamp Pabu
France Investigational site Irigny
France Cabinet Médical La Chaussee St Victor
France Sarthe et Loir / Médecine IV Hospital La Fleche
France Hospital Les Oudairies La Roche Sur Yon Cedex
France Centre Hospitalier Departemental Les Oudairies La roche Sur Yon Cedex 9
France Cabinet Médical La Varenne St Hilaire
France CH Lagny Marne La Vallee Lagny Sur Marne
France Clinique St Ame Lambres les Douai
France Investigational site Lannion
France Investigational site Le Cannet
France Clinique bon Secours Le Puy En Velay
France Cabinet Médical Lille
France Investigational site Limoges
France Polyclinique de Lisieux Lisieux
France Investigational site Lorient
France Hopital Prive Jean Mermoz Lyon Cedex 8
France Hopital Privé Jean Mermoz Lyon Cedex 8
France Cabinet Médical Marseille
France Hopital Clinique Claude Bernard Metz
France HPM Site Sainte-Andre Metz
France Private hospital of Metz Metz
France CHG Montauban Montauban Cedex
France Cabinet Médical Montelimard
France Centre Hospitalier Montélimard Montelimard
France Investigational site Montelimard
France Centre Hospitalier Montelimard Montelimard CEDEX
France CHI Le Raincy Montfermeil Montfermeil
France Hospital Le Raincy Montfermeil Montfermeil
France Cabinet Médical Montpellier
France Hospital Saint Eloi Montpellier
France Hopital Saint Eloi Montpellier CEDEX 5
France Investigational site Montrouge
France Cabinet Médical Mulhouse
France Centre Erdre-Saint Augustin Nantes
France Centre Medical Erdre-St Augustin Nantes
France Centre Médical Erdre-St Augustin Nantes
France Investigational site Narbonne
France Cabinet Médical Nice
France Investigational site Nice
France CHU de Nice-Hopital de l'Archet Nice Cedex 3
France Cabinet Médical Nimes
France Le Méridien Nimes
France Investigational site Niort
France Hopital de Guingamp Pabu
France Cabinet Médical Paris
France Clinique du Louvre Paris
France Investigational site Paris
France Centre Hospitalier de Perpignan Perpignan
France Cabinet Médical Prades
France Centre Hospitalier d'Annecy Pringy Cedex
France Cabinet Médicale Quevert
France Investigational site Reims
France Clinique La Sagesse Rennes
France Investigational site Riom
France Investigational site Rodez
France Clinique de l'Europe Rouen
France Clinique Mathilde Rouen
France Investigational site Saint Brieuc
France Investigational site Saint Jean de Luz
France Cabinet Lamartine Saint Nazaire
France Investigational site Saint Quentin
France Centre Médical des Châtaigniers Saint-herblain
France Cabinet Médical Saint-Jean-De-Vedas
France Cabinet Médical Sarreguemines
France Investigational site Sarreguemines
France Cabinet Médical Saumur
France Cabinet Médical Savigny sur orge
France Cabinet Médical Sevran
France Centre Hospitalier Prive Saint Gregoire St Gregoire
France Centre Hospitalier Privé Saint Gregoire St Gregoire
France Investigational site St Lo
France Polyclinique de l'Ocean St Nazaire
France Polyclinique de l'Océan St Nazaire
France Investigational site St Raphael
France Cabinet Médical Strasbourg
France Cabinet Médical Sucy en Brie
France Investigational site Tarbes
France Investigational site Thionville
France Cabinet Médical Toulon
France Clinic Saint Jean Languedoc Toulouse
France Investigational site Toulouse
France Cabinet Médical Tourcoing
France Centre Hospitalier de Tourcoing-Hôpital DRON Tourcoing
France Investigational site Tournefeuille
France Cabinet Médical Troyes
France Clinic Valence
France Centre Hospitalier de Valence Valence Cedex 9
France Hospital of Valence Valence Cedex 9
France Centre Hospitalier de Valenciennes Valenciennes
France Investigational site Vannes
France Cabinet Médical Vendome
France Groupe hospitalier les Portes du Sud Venissieux
France Groupe Hospitalier Mutualiste "Les Portes du Sud" Venissieux
France Groupe Hospitalier Mutualiste Les Portes du Sud Venissieux
France Centre Futura Medica Verguigneul
France Investigational site Vernon
France Cabinet Médical Vesoul
France Centre Chirurgical St laurent Villemoisson sur orge
France Hospital of Villeneuve Saint Georges Villeneuve saint georges
France CH Villeneuve Saint Georges Villeneuve Saint Georges Cedex
France CHIV Villeneuve Saint-Georges
France Cabinet Médical Vincennes
France Investigational site Vincennes

Sponsors (1)

Lead Sponsor Collaborator
Ferring Pharmaceuticals

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Remission rate (ulcerative colitis) - calculated by UCCS (Ulcerative Colitis Clinical Score) From baseline (inclusion visit) and at 1 year interval after baseline Yes
Primary Remission rate (ulcerative colitis) - calculated by UCCS (Ulcerative Colitis Clinical Score) From baseline (inclusion visit) and at 2 year interval after baseline Yes
Primary Remission rate (ulcerative colitis) - calculated by UCCS (Ulcerative Colitis Clinical Score) From baseline (inclusion visit) and at 3 year interval after baseline Yes
Secondary Remission rate (endoscopic) - calculated by UC-DAI (Ulcerative Colitis Disease Activity Index) From baseline (inclusion visit) and at 1 year interval after baseline Yes
Secondary Assessing treatment adherence by patient's completion of questionnaire MMAS-8 (Modified Morisky Adherence Scale) From baseline (inclusion visit) and at 1 year interval after baseline No
Secondary Occurence/number of adverse events From baseline (inclusion visit) to year 3 after baseline Yes
Secondary Colonoscopy (if available) - assessing endoscopic activity of the ulcerative colitis From baseline (inclusion visit) to 3 year after baseline Yes
Secondary Remission rate (endoscopic) - calculated by UC-DAI (Ulcerative Colitis Disease Activity Index) From baseline (inclusion visit) and at 2 year interval after baseline Yes
Secondary Remission rate (endoscopic) - calculated by UC-DAI (Ulcerative Colitis Disease Activity Index) From baseline (inclusion visit) and at 3 year interval after baseline Yes
Secondary Assessing treatment adherence by patient's completion of questionnaire MMAS-8 (Modified Morisky Adherence Scale) From baseline (inclusion visit) and at 2 year interval after baseline No
Secondary Assessing treatment adherence by patient's completion of questionnaire MMAS-8 (Modified Morisky Adherence Scale) From baseline (inclusion visit) and at 3 year interval after baseline No
See also
  Status Clinical Trial Phase
Recruiting NCT05702879 - Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
Not yet recruiting NCT05953402 - A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Recruiting NCT03950232 - An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT03124121 - Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Phase 4
Not yet recruiting NCT06100289 - A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Phase 3
Withdrawn NCT04209556 - A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis Phase 2
Terminated NCT00061282 - Clotrimazole Enemas for Pouchitis in Children and Adults Phase 1/Phase 2
Recruiting NCT04398550 - SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis N/A
Recruiting NCT04314375 - Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis Phase 4
Active, not recruiting NCT04857112 - Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis Phase 2
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Active, not recruiting NCT04033445 - A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis Phase 2/Phase 3
Recruiting NCT05428345 - A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Active, not recruiting NCT06221995 - Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
Recruiting NCT04767984 - Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Phase 2
Completed NCT02508012 - Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases N/A
Recruiting NCT06071312 - FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach Phase 1/Phase 2
Completed NCT03760003 - Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis Phase 2
Not yet recruiting NCT05539625 - Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis Phase 2